S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|"ARGUS Connect" Global Customer Conference to Deliver Industry Insights and Technology Directions, April 7-9, 2015 (2014/12/17)|
|Second Sight Announces First Commercial Implants of the Argus® II Retinal Prosthesis System in France (2015/2/24)|
|Health Canada Approves Second Sight’s Argus II Retinal Prosthesis System for Treatment of Outer Retinal Degeneration (2015/1/12)|
|Second Sight Receives Highest Priority Reimbursement for Argus II in Germany (2015/2/3)|
|Seattle Genetics Initiates Phase 1b Trial of SGN-CD33A in Combination with Frontline Standard of Care and as Consolidation Therapy for Acute Myeloid Leukemia (2014/12/18)|
|Aptose Biosciences Presents APTO-253 Preclinical Data at 56th American Society of Hematology Annual Meeting (2014/12/9)|
|Harold Hamm Says U.S. Oil Firms Can Help Right the Market (2015/1/28)|
|New Data at ASH 2014 Highlight Progress of Pfizer’s Growing Portfolio in Blood Cancers (2014/12/9)|
|CTI BioPharma Announces Comprehensive Kinome Analysis that Demonstrates Pacritinib Inhibits Kinases Linked to a Spectrum of Blood-Related Cancers (2014/12/6)|
|Bio-Path Holdings Starts Phase II Study with Liposomal Grb-2 in AML Patients (2015/2/9)|
Click above to view more mutual fund data and stats for aml - Argus Corporation Limited.